Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response

Background: The rapid development of immunotherapy has significantly improved patient outcomes in recent years. CD93, a novel biomarker expressed on vascular endothelial cells, is essential for tumor angiogenesis. Recent studies have shown that CD93 is closely related to immune cell infiltration and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Wen, Wang, Guangyu, Zhu, Liuyang, Bai, Yi, Liu, Zirong, Yang, Long, Wu, Hao, Cui, Tao, Zhang, Yamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900912/
https://www.ncbi.nlm.nih.gov/pubmed/35265666
http://dx.doi.org/10.3389/fmolb.2021.793445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900912/
https://www.ncbi.nlm.nih.gov/pubmed/35265666
http://dx.doi.org/10.3389/fmolb.2021.793445

Ejemplares similares